Park Avenue Securities’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
WA
CAM
RP
PCM
EOJOAM
CF
MNBTD
GIA
Park Avenue Securities's RGEN Position: Q2 2026 in Review
Park Avenue Securities increased its Repligen (RGEN) stake by 35% in Q2 2026, buying an estimated $77.8K and bringing the position to 2,463 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #1466.
Park Avenue Securities first reported a position in RGEN in Q3 2021 and has held it in 16 quarters since. The position peaked at $843K in Q3 2021. 60 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Park Avenue Securities held 2,463 shares of Repligen worth $336K as of Q2 2026.
- Park Avenue Securities bought 633 Repligen shares in Q2 2026, an estimated $77.8K.
- Repligen made up ﹤0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1466 holding.
- Park Avenue Securities first reported a position in Repligen in Q3 2021 and has held it in 16 quarters since.
- Park Avenue Securities's Repligen position peaked at $843K in Q3 2021.
- 60 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.